Carlsbad
(760) 431-2273
Murrieta
(951) 600-9803
Ontario
(909) 947-3600
OPEN 24
HOURS
Invisible virus is being evaluated as the next generation of compassionate cancer cures
August 10, 2012



The investigative FOXNews journalists caught up with the clinicians, nurses and researchers at California Veterinary Specialists Angel Care Cancer Center to learn how an invisible virus is being evaluated as the next generation of compassionate cancer cures in dogs, cats and people. Angel Care Cancer Center, a separate but allied non-profit research organization, the Special Care Foundation for Companion Animals and the San Diego based company Genelux have teamed up to affirm the safety an efficacy of a new cancer killing virus. The therapy includes a modification of a virus that has been used worldwide to wipe out smallpox as a threat to human health. Families who bring their beloved pets with cancer to Angel Care seek the highest level of advanced yet gentle cancer care and novel, new therapies that are likely to become the therapies of the future. The purpose of the study is to determine the optimum way of treating these dogs with cancer while taking these results to develop new approaches to enhance the cure rates in children and adults.

The CVS Angel Care Cancer Center is a comprehensive cancer center that provides direct care for patients with cancer and their families. This team offers innovative clinical research to provide the very best diagnostics and treatments available to fight against cancer. They are a group of veterinarians, veterinary nurses, and human physicians that share a mutual philosophy: science may provide a cure, but compassionate care comes from the heart. The goal is to do everything possible to not only win the fight against cancer, but to ensure the treatment is healing, not hurting.


RELATED ARTICLES
Cancer Therapy Revolution LW-2 Canine Therapy Study
May 20, 2014
There are currently very promising developments in the treatment of canine cancer that focus on the natural immune response of the body. Cancer cells secrete elements into the blood that inhibit the immune system from killing them. The LW-2 Canine Therapy focuses on removing these harmful elements without the use of drugs, chemicals, radiation, or complicated surgical procedures. This approach is also intended to limit the possibilities and side effects traditionally associated with cancer treatments.
Pedal the Cause: A World Without Cancer Fundraiser
Aug 12, 2014
The word cancer is as dark and empty as the disease it defines. A diagnosis of cancer often brings with it feelings of overwhelming fear, a spiraling sense of loss of control, and most devastating of all, the loss of hope. This occurs regardless of whether the patient is a human family member or a precious pet. I know, because I am a veterinary oncologist at California Veterinary Specialists Angel Care Cancer Center and am given the honor of doing everything I can to defeat cancer in my animal patients with compassionate care. Like my fellow...
CVS Advances New Therapy for Dogs with T Cell Lymphoma
Nov 19, 2014
Investigators from California Veterinary Specialists empowered by funding from the Special Care Foundation for Companion Animals, has worked with the discovery team led by Dr. Genevieve Hansen to develop a novel therapy for T-cell lymphoma in dogs. The veterinary oncologists and nurses at all three CVS hospitals (Murrieta, Ontario and Carlsbad) executed a series of clinical and basic science trials to document the safety and efficacy of the monoclonal antibody therapy that triggers the immune system to kill the T cell lymphoma cancer cells ...
Dr. Ogilvie Featured on KUSI-TV
Jun 12, 2013
In case you missed it, check out last week’s KUSI-TV live segment with Dr. Ogilvie as he discusses cancer treatment for animals.
Pedal the Cause: A World Without Cancer Fundraiser Part 2
Sep 25, 2014
Dr. Gregory Ogilvie, director of the CVS Angel Care Cancer Center, actively participated in and raised money for Pedal the Cause bike ride, a non-profit dedicated to raising money for cancer research at San Diego's three NCI-designated Cancer Institutes; UCSD Moores Cancer Center, The Salk Institute and Sanford-Burnham Medical Research Institute. The two-day ride covered 150 miles from La Jolla to Temecula. Pedal the Cause granted $425,000 from the 2013 ride and is expected to double that amount thanks to the brave donors who helped make t...